TPM3 and cancer: There are three key features of our recommendations: (1) To reasonable assign appropriate test to patients with different cancer types, we classify cancer types into three types based on: (i) whether next‐generation sequencing (NGS) is commonly performed, (ii) whether TRK protein is physiologically expressed, and (iii) whether NTRK gene fusion is prevalent.